Capital Analysts LLC’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$213K Sell
796
-66
-8% -$18.3K 0.01% 626
2025
Q4
$237K Sell
862
-1,139
-57% -$319K 0.01% 587
2025
Q3
$577K Sell
2,001
-75
-4% -$22.2K 0.02% 398
2025
Q2
$686K Sell
2,076
-11,302
-84% -$3.64M 0.02% 335
2025
Q1
$4.4M Buy
13,378
+1,007
+8% +$303K 0.16% 114
2024
Q4
$3.42M Buy
12,371
+1,088
+10% +$347K 0.14% 126
2024
Q3
$3.91M Buy
11,283
+1,538
+16% +$529K 0.16% 117
2024
Q2
$3.22M Buy
9,745
+721
+8% +$249K 0.14% 125
2024
Q1
$3.28M Buy
9,024
+112
+1% +$36.9K 0.15% 116
2023
Q4
$2.67M Buy
8,912
+158
+2% +$46.2K 0.13% 132
2023
Q3
$2.5M Buy
8,754
+81
+0.9% +$23.1K 0.14% 125
2023
Q2
$2.43M Buy
8,673
+238
+3% +$62K 0.14% 132
2023
Q1
$2.15M Sell
8,435
-173
-2% -$50.4K 0.12% 143
2022
Q4
$2.85M Sell
8,608
-167
-2% -$52.8K 0.17% 117
2022
Q3
$2.44M Buy
8,775
+7,441
+558% +$2.09M 0.17% 123
2022
Q2
$351K Buy
1,334
+25
+2% +$6.44K 0.02% 290
2022
Q1
$314K Sell
1,309
-186
-12% -$43.5K 0.02% 301
2021
Q4
$343K Buy
1,495
+5
+0.3% +$1.06K 0.02% 298
2021
Q3
$298K Buy
1,490
+205
+16% +$44.6K 0.02% 300
2021
Q2
$305K Buy
1,285
+87
+7% +$21.7K 0.02% 295
2021
Q1
$290K Sell
1,198
-20
-2% -$4.46K 0.02% 294
2020
Q4
$254K Sell
1,218
-469
-28% -$92K 0.02% 227
2020
Q3
$286K Buy
1,687
+879
+109% +$155K 0.03% 231
2020
Q2
$152K Sell
808
-273
-25% -$51.8K 0.02% 241
2020
Q1
$192K Sell
1,081
-35
-3% -$6.79K 0.02% 214
2019
Q4
$228K Buy
1,116
+125
+13% +$22.9K 0.02% 227
2019
Q3
$150K Buy
991
+148
+18% +$24.1K 0.02% 241
2019
Q2
$133K Buy
843
+798
+1,773% +$125K 0.01% 251
2019
Q1
$7K Sell
45
-57
-56% -$10.4K ﹤0.01% 536
2018
Q4
$19K Buy
+102
New +$21.3K ﹤0.01% 406
2016
Q2
Sell
-493
Closed -$67.7K 336
2016
Q1
$67.7K Hold
493
0.01% 246
2015
Q4
$72.1K Sell
493
-493
-50% -$67.8K 0.01% 247
2015
Q3
$133K Buy
986
+493
+100% +$71.6K 0.03% 208
2015
Q2
$79.9K Buy
+493
New +$68.1K 0.02% 232

Other funds holding CI

Capital Analysts LLC's CI Position: Q1 2026 in Review

Capital Analysts LLC reduced its Cigna (CI) stake by 7.7% in Q1 2026, selling an estimated $18.3K and leaving 796 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #626.

Capital Analysts LLC first reported a position in CI in Q2 2015 and has held it in 34 quarters since. The position peaked at $4.4M in Q1 2025. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Capital Analysts LLC held 796 shares of Cigna worth $213K as of Q1 2026.
  • Capital Analysts LLC sold 66 Cigna shares in Q1 2026, an estimated $18.3K.
  • Cigna made up 0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #626 holding.
  • Capital Analysts LLC first reported a position in Cigna in Q2 2015 and has held it in 34 quarters since.
  • Capital Analysts LLC's Cigna position peaked at $4.4M in Q1 2025.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.